Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Reshma Rangwala, Yunyoung C. Chang, Janice Hu, Kenneth M. Algazy, Tracey L. Evans, Leslie A. Fecher, Lynn M. Schuchter, Drew A. Torigian, Jeffrey T. Panosian, Andrea B. Troxel, Kay See Tan, Daniel F. Heitjan, Angela M. DeMichele, David J. Vaughn, Maryann Redlinger, Abass Alavi, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Peter J. O'DwyerRavi K. Amaravadi

Research output: Contribution to journalArticlepeer-review

243 Scopus citations

Fingerprint Dive into the research topics of 'Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences